Rilmenidine Phosphate is an oxazole-derived agonist of adrenergic receptor α2 and Imidazoline receptor, used in trials studying the treatment of hypertension and chronic kidney disease.
More Information Supplier Page
Rilmenidine Phosphate is an oxazole-derived agonist of adrenergic receptor α2 and Imidazoline receptor, used in trials studying the treatment of hypertension and chronic kidney disease.
More Information Supplier Page Rilmenidine Phosphate is an oxazole-derived agonist of adrenergic receptor α2 and Imidazoline receptor, used in trials studying the treatment of hypertension and chronic kidney disease.
More Information Supplier Page 
Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of 1.5 hours.
More Information Supplier Page
Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of 1.5 hours.
More Information Supplier Page
Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of 1.5 hours.
More Information Supplier Page 
Rolipram is a selective inhibitor of phosphodiesterases PDE 4, especially the PDE 4B with IC50 of 130 nM while IC50 for PDE4D is 240 nM, it’s an anti-inflammatory agent.
More Information Supplier Page
Rolipram is a selective inhibitor of phosphodiesterases PDE 4, especially the PDE 4B with IC50 of 130 nM while IC50 for PDE4D is 240 nM, it’s an anti-inflammatory agent.
More Information Supplier Page
Ro 31-8220 mesylate is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively.
More Information Supplier Page
Ro 31-8220 mesylate is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively.
More Information Supplier Page
